Clinical Trials for OM Pharma

Explore 8 clinical trials worldwide

Showing 1-8 of 8 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: OM Pharma

Clinical Trials (8)

NCT06851559
A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks
PHASE2Not yet recruiting
80 participants
Started: Dec 31, 2025 · Completed: Mar 31, 2027
1 condition1 sponsor0 locations
NCT06660342
A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
N/ARecruiting
728 participants
Started: May 15, 2025 · Completed: Sep 30, 2034
4 conditions1 sponsor1 location
NCT06655272
OM 85 to Prevent Respiratory Infections in Older At Risk Patients
PHASE4Recruiting
360 participants
Started: Feb 1, 2025 · Completed: Apr 30, 2026
1 condition2 sponsors1 location
NCT07178002
OM 85 to Prevent Respiratory Infections in Older At Risk Patients
PHASE4Active, not recruiting
360 participants
Started: Dec 19, 2024 · Completed: Apr 30, 2026
1 condition2 sponsors1 location
NCT06345014
The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome
PHASE4Recruiting
332 participants
Started: Dec 20, 2023 · Completed: Mar 30, 2026
3 conditions2 sponsors1 location
NCT05857930
A Study to Assess the Efficacy and Safety of Daily OM-85 in Young Children With Recurrent Wheezing
PHASE2Recruiting
288 participants
Started: Jun 20, 2023 · Completed: Sep 30, 2026
2 conditions1 sponsor39 locations
NCT05677763
OM-85 in Paediatric Recurrent Respiratory Tract Infections With Wheezing Lower Respiratory Illness
PHASE4Active, not recruiting
525 participants
Started: Dec 12, 2022 · Completed: Sep 28, 2026
2 conditions1 sponsor42 locations
NCT04167813
Trial of Ondansetron as a Parkinson's HAllucinations Treatment
PHASE2Active, not recruiting
168 participants
Started: Oct 1, 2021 · Completed: Aug 30, 2024
2 conditions7 sponsors23 locations